A world leader in the field of in vitro diagnostics for over 40
years, bioMérieux is present in more than 150 countries through 35
subsidiaries and a large network of distributors. In 2006, revenues
reached over €1 billion with 83% of sales outside of France.
bioMérieux provides diagnostic solutions (reagents, instruments,
software) which determine the source of disease and contamination to
improve patient health and ensure consumer safety. Our products are
used for diagnosing infectious diseases and providing high medical
value results for cardiovascular emergencies and cancer screening
and monitoring. They are also used for detecting microorganisms in
agri-food, pharmaceutical and cosmetic products. bioMérieux is
listed on Eurolist by Euronext.
Clinical diagnostics website: